CAGNONI PABLO J
Insider CIK 1205703 · ONXX EVP, Global R&D and Tech Ops · CRSP Director · RUBY Chief Executive Officer, Director · FUSN Director · INCY President, R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INCY INCYTE CORP | M Exercise deriv | 2026-10-15 | 2026-10-19 | 925 | — | $0 | 19,431 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-10-15 | 2026-10-19 | 455 | — | $0 | 4,096 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-10-15 | 2026-10-19 | 423 | — | $0 | 3,802 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-10-15 | 2026-10-19 | 839 | — | $0 | 17,627 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-10-15 | 2026-10-19 | 2,642 | $112.71 | $297.8K | 183,200 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-10-15 | 2026-10-19 | 925 | $64.25 | $59.4K | 185,842 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-10-15 | 2026-10-19 | 455 | $61.18 | $27.8K | 184,917 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-10-15 | 2026-10-19 | 423 | $61.76 | $26.1K | 184,462 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-10-15 | 2026-10-19 | 839 | $71.93 | $60.3K | 184,039 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-09-15 | 2026-09-17 | 9,233 | — | $0 | 18,466 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-09-15 | 2026-09-17 | 4,551 | — | $0 | 4,551 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-09-15 | 2026-09-17 | 6,477 | — | $0 | 20,356 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-09-15 | 2026-09-17 | 2,957 | — | $0 | 4,225 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-09-15 | 2026-09-17 | 2,957 | $61.76 | $182.6K | 186,157 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-09-15 | 2026-09-17 | 4,551 | $61.18 | $278.4K | 190,708 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-09-15 | 2026-09-17 | 6,477 | $64.25 | $416.1K | 197,185 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-09-15 | 2026-09-17 | 9,233 | $71.93 | $664.1K | 206,418 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-09-15 | 2026-09-17 | 13,985 | $120.49 | $1.69M | 183,200 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-09-15 | 2026-09-17 | 9,233 | $120.50 | $1.11M | 197,185 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-09-15 | 2026-09-17 | 9,233 | — | $0 | 18,466 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-09-15 | 2026-09-17 | 6,477 | — | $0 | 20,356 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-09-15 | 2026-09-17 | 4,551 | — | $0 | 4,551 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-09-15 | 2026-09-17 | 2,957 | — | $0 | 4,225 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-09-15 | 2026-09-17 | 13,985 | $120.49 | $1.69M | 183,200 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-09-15 | 2026-09-17 | 9,233 | $120.50 | $1.11M | 197,185 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-09-15 | 2026-09-17 | 9,233 | $71.93 | $664.1K | 206,418 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-09-15 | 2026-09-17 | 6,477 | $64.25 | $416.1K | 197,185 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-09-15 | 2026-09-17 | 4,551 | $61.18 | $278.4K | 190,708 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-09-15 | 2026-09-17 | 2,957 | $61.76 | $182.6K | 186,157 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-08-19 | 2026-08-20 | 10,801 | $125.56 | $1.36M | 183,200 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-08-19 | 2026-08-20 | 10,801 | $125.56 | $1.36M | 183,200 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-08-12 | 2026-08-14 | 10,803 | $120.04 | $1.30M | 194,001 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-08-12 | 2026-08-14 | 10,803 | $120.04 | $1.30M | 194,001 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-08-05 | 2026-08-07 | 10,640 | $122.69 | $1.31M | 204,804 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-08-05 | 2026-08-07 | 10,640 | $122.69 | $1.31M | 204,804 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-07-31 | 2026-08-04 | 15,888 | $119.70 | $1.90M | 215,444 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-07-31 | 2026-08-04 | 15,888 | $119.70 | $1.90M | 215,444 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2026-07-16 | 2026-07-20 | 57,861 | — | $0 | 57,861 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2026-07-16 | 2026-07-20 | 33,508 | — | $0 | 33,508 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-07-16 | 2026-07-20 | 13,403 | — | $0 | 231,332 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2026-07-15 | 2026-07-16 | 4,950 | $115.09 | $569.7K | 217,929 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2026-07-14 | 2026-07-16 | 17,969 | $114.88 | $2.06M | 222,879 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2026-06-01 | 2026-06-03 | 25,469 | $95.59 | $2.43M | 240,848 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-05-06 | 2026-05-20 | 31,517 | — | $0 | 266,317 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-04-17 | 2026-04-21 | 12,590 | — | $0 | 27,699 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-04-17 | 2026-04-21 | 6,077 | — | $0 | 26,833 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-04-17 | 2026-04-21 | 12,590 | $71.93 | $905.6K | 281,359 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-04-17 | 2026-04-21 | 18,667 | $96.50 | $1.80M | 262,692 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-04-17 | 2026-04-21 | 6,077 | $64.25 | $390.4K | 268,769 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-04-15 | 2026-04-17 | 27,892 | — | $0 | 262,692 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-03-17 | 2026-03-19 | 7,166 | — | $0 | 9,102 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-03-17 | 2026-03-19 | 11,501 | — | $0 | 32,910 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-03-17 | 2026-03-19 | 18,667 | $94.24 | $1.76M | 234,800 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-03-17 | 2026-03-19 | 7,166 | $61.18 | $438.4K | 241,966 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-03-17 | 2026-03-19 | 11,501 | $64.25 | $738.9K | 253,467 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-02-19 | 2026-02-23 | 5,575 | — | $0 | 16,268 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-02-19 | 2026-02-23 | 13,093 | — | $0 | 7,182 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-02-19 | 2026-02-23 | 13,093 | $61.76 | $808.6K | 247,893 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-02-19 | 2026-02-23 | 18,668 | $100.91 | $1.88M | 234,800 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-02-19 | 2026-02-23 | 5,575 | $61.18 | $341.1K | 253,468 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2026-01-16 | 2026-01-21 | 28,475 | — | $0 | 28,475 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2025-07-15 | 2025-07-16 | 43,846 | — | $0 | 43,846 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2025-07-15 | 2025-07-16 | 39,471 | — | $0 | 39,471 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2025-07-15 | 2025-07-16 | 2,628 | $68.25 | $179.4K | 217,262 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-07-15 | 2025-07-16 | 17,538 | — | $0 | 234,800 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2025-07-14 | 2025-07-16 | 1,280 | $69.98 | $89.6K | 219,890 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2025-01-17 | 2025-01-22 | 40,289 | — | $0 | 40,289 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2024-07-15 | 2024-07-17 | 44,411 | — | $0 | 44,411 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-07-15 | 2024-07-17 | 19,851 | — | $0 | 221,919 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2024-07-15 | 2024-07-17 | 749 | $64.25 | $48.1K | 221,170 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 141,011 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 30,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2024-01-18 | 2024-01-22 | 21,843 | — | $0 | 21,843 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2023-07-14 | 2023-07-18 | 20,275 | — | $0 | 20,275 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-07-14 | 2023-07-18 | 9,668 | — | $0 | 202,068 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-06-05 | 2023-06-07 | 179,613 | — | $0 | 179,613 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-06-05 | 2023-06-21 | 192,400 | — | $0 | 192,400 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-01 | 8,448 | $0.25 | $2.1K | 66,082 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2023-01-31 | 2023-01-31 | 25,000 | — | $0 | 75,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2023-01-31 | 2023-01-31 | 7,240 | $0.24 | $1.7K | 74,530 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2023-01-31 | 2023-01-31 | 25,000 | — | $0 | 81,770 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2023-01-29 | 2023-01-31 | 21,250 | — | $0 | 42,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2023-01-29 | 2023-01-31 | 21,250 | — | $0 | 56,770 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | S Sale | 2022-02-01 | 2022-02-01 | 6,730 | $6.57 | $44.2K | 35,520 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-01 | 365,000 | — | $0 | 365,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2022-01-29 | 2022-02-01 | 21,250 | — | $0 | 63,750 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2022-01-29 | 2022-02-01 | 21,250 | — | $0 | 42,250 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2021-01-29 | 2021-02-02 | 85,000 | — | $0 | 85,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2021-01-29 | 2021-02-02 | 375,000 | — | $0 | 375,000 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2020-06-25 | 2020-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | P Buy | 2020-04-14 | 2020-04-15 | 21,000 | $4.70 | $98.7K | 21,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2020-01-31 | 2020-02-03 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-11-19 | 2019-11-21 | 7,500 | — | $0 | 63,833 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-11-19 | 2019-11-21 | 7,500 | $62.00 | $465.0K | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-11-19 | 2019-11-21 | 7,500 | $5.59 | $41.9K | 7,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-11-12 | 2019-11-13 | 7,500 | — | $0 | 71,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-11-12 | 2019-11-13 | 7,500 | $55.00 | $412.5K | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-11-12 | 2019-11-13 | 7,500 | $5.59 | $41.9K | 7,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-10-30 | 2019-11-01 | 7,500 | — | $0 | 78,833 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-10-30 | 2019-11-01 | 7,500 | $52.00 | $390.0K | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-10-30 | 2019-11-01 | 7,500 | $5.59 | $41.9K | 7,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2019-01-31 | 2019-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2018-10-31 | 2018-11-01 | 164,400 | — | $0 | 164,400 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2018-10-31 | 2018-11-01 | 193,400 | — | $0 | 193,400 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2018-07-05 | 2018-07-05 | 1,684 | — | $0 | 86,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2018-07-05 | 2018-07-05 | 1,684 | $5.59 | $9.4K | 1,684 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-07-05 | 2018-07-05 | 1,684 | $62.00 | $104.4K | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2018-07-03 | 2018-07-05 | 5,816 | — | $0 | 88,017 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-07-03 | 2018-07-05 | 5,816 | $62.00 | $360.6K | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2018-07-03 | 2018-07-05 | 5,816 | $5.59 | $32.5K | 5,816 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-06-15 | 2018-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2017-05-31 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2016-10-18 | 2016-10-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 34,030 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2013-10-01 | 2013-10-03 | 16,257 | $125.00 | $2.03M | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2013-03-11 | 2013-03-13 | 34,030 | — | $0 | 34,030 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2013-03-11 | 2013-03-13 | 16,257 | — | $0 | 16,257 | SEC↗ |